GO:0048630 skeletal muscle tissue growth: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048630 (skeletal muscle tissue growth) is defined as the increase in size or mass of a skeletal muscle, which may result from changes in muscle fiber number or fiber size.
• Myostatin (MSTN) is a key negative regulator of skeletal muscle growth; its loss leads to dramatic muscle hyperplasia and hypertrophy in mice.
• Satellite cells are the primary stem cell population driving postnatal skeletal muscle growth and regeneration through self-renewal and differentiation.
• Skeletal muscle growth is studied across species, including hibernating mammals that prioritize muscle protein synthesis for emergence, and in clinical contexts such as cancer cachexia and sarcopenia.
• Human skeletal muscle-derived mesenchymal stem/stromal cells and bovine satellite cells provide tractable in vitro models for studying growth kinetics and differentiation.
• Lifestyle interventions such as resistance training and time-restricted eating are being investigated for their effects on skeletal muscle quantity, quality, and function in aging populations.
Description
Skeletal muscle tissue growth (GO:0048630) is a fundamental biological process defined as the increase in size or mass of a skeletal muscle, which may be due to a change in the fiber number or size. This process is central to organismal development, metabolic homeostasis, and physical performance, and its dysregulation underlies numerous pathological conditions including muscle wasting diseases, sarcopenia, and cachexia. Understanding the molecular and cellular mechanisms that govern skeletal muscle growth is therefore of broad biomedical importance. The discovery that myostatin (MSTN), a TGF-beta superfamily member, acts as a negative regulator of muscle mass provided a landmark insight into the genetic control of this process. Subsequent research has elucidated the roles of satellite cells, the resident muscle stem cells, in driving postnatal growth and regeneration through self-renewal and differentiation. Moreover, comparative studies in hibernating mammals have revealed that skeletal muscle growth can be prioritized for emergence from hibernation, highlighting the evolutionary plasticity of this process. In clinical settings, the assessment of skeletal muscle tissue quantity and quality is critical for understanding conditions such as cancer cachexia and for evaluating interventions like resistance training and time-restricted eating in postmenopausal women. Advances in isolating and culturing skeletal muscle satellite cells and mesenchymal stem/stromal cells have provided powerful in vitro platforms to dissect the cellular and molecular basis of muscle growth. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0048630, covering its definition, mechanisms, key genes, disease relevance, and research methodologies.
skeletal muscle tissue growth At A Glance
| GO ID | GO:0048630 |
|---|---|
| GO term | skeletal muscle tissue growth |
| Ontology | biological_process |
| Synonym | None |
| Definition | The increase in size or mass of a skeletal muscle. This may be due to a change in the fiber number or size. |
| Major function | Regulation of muscle mass through changes in fiber number (hyperplasia) or fiber size (hypertrophy) |
| Key regulator | Myostatin (MSTN), a negative regulator of muscle growth |
| Cellular driver | Satellite cells (muscle stem cells) |
| Physiological context | Postnatal development, regeneration, hibernation emergence |
| Clinical relevance | Sarcopenia, cachexia, metabolic disorders |
What Is GO:0048630?
According to the Gene Ontology, GO:0048630 (skeletal muscle tissue growth) is defined as the increase in size or mass of a skeletal muscle. This increase may be attributed to a change in the number of muscle fibers (hyperplasia) or the size of existing fibers (hypertrophy). The term encompasses the biological processes that lead to greater muscle tissue mass, including myofiber hypertrophy, satellite cell proliferation and fusion, and the associated anabolic signaling pathways.
Why Is skeletal muscle tissue growth Important in Cell Biology?
Skeletal muscle tissue growth is critically important because skeletal muscle is the most abundant tissue in the human body, accounting for approximately 40% of body mass, and plays central roles in locomotion, metabolism, and thermoregulation. Dysregulation of muscle growth contributes to debilitating conditions such as sarcopenia, cancer cachexia, and muscular dystrophies, making it a major focus of biomedical research. Understanding the mechanisms that control muscle growth can inform therapeutic strategies to preserve or restore muscle mass in aging and disease.
• Skeletal muscle growth is essential for postnatal development and physical performance.
• Myostatin (MSTN) acts as a negative regulator; its inhibition increases muscle mass, offering therapeutic potential for muscle-wasting diseases.
• Satellite cell function is required for muscle growth and regeneration; their decline contributes to sarcopenia.
• Skeletal muscle serves as an experimental model to study tissue aging and rejuvenation.
• Cancer cachexia involves profound loss of skeletal muscle mass, and understanding growth mechanisms may identify therapeutic targets.
• Hibernating mammals prioritize skeletal muscle growth for emergence, revealing adaptive mechanisms that could inspire interventions.
• Resistance training and dietary interventions can modulate muscle quantity and quality in at-risk populations.
• In vitro models using bovine and human satellite cells enable mechanistic studies of muscle growth.
What Happens During skeletal muscle tissue growth?
Satellite Cell Activation and Proliferation
In simple terms: Muscle stem cells wake up and multiply to provide new nuclei for growing muscle fibers.
Skeletal muscle growth relies on satellite cells, a population of resident muscle stem cells located between the basal lamina and the sarcolemma of muscle fibers. Upon activation by growth factors or injury, satellite cells proliferate to expand the pool of myogenic precursor cells. This proliferation is a prerequisite for both hyperplasia (increase in fiber number) and hypertrophy (increase in fiber size). The self-renewal capacity of satellite cells ensures that a stem cell pool is maintained for future growth and regeneration.
Myoblast Differentiation and Fusion
In simple terms: The multiplied muscle precursor cells fuse together or with existing fibers to make them bigger or to form new fibers.
After proliferation, satellite cell-derived myoblasts exit the cell cycle and differentiate, expressing muscle-specific proteins such as myogenin and MRF4. These myoblasts then fuse with each other to form new myotubes or with existing muscle fibers to donate their nuclei, a process essential for muscle hypertrophy. This fusion step directly contributes to the increase in muscle fiber size and protein content that defines skeletal muscle tissue growth.
Protein Synthesis and Myofibrillar Accretion
In simple terms: Muscle fibers build more contractile proteins, making them thicker and stronger.
Muscle hypertrophy requires a net increase in protein synthesis over degradation. Anabolic signaling pathways, particularly mTORC1, promote translation of myofibrillar proteins such as myosin and actin, leading to the expansion of the contractile apparatus. In hibernating mammals, skeletal muscle growth is prioritized for emergence, indicating that protein synthesis can be upregulated in response to specific physiological demands.
Negative Regulation by Myostatin
In simple terms: A protein called myostatin puts the brakes on muscle growth; removing it leads to bigger muscles.
Myostatin (MSTN), a member of the TGF-beta superfamily, is a potent negative regulator of skeletal muscle growth. Mice lacking myostatin exhibit a dramatic increase in muscle mass due to both hyperplasia and hypertrophy, demonstrating that myostatin normally limits muscle growth. Myostatin signaling through activin receptors and Smad transcription factors inhibits myoblast proliferation and differentiation, thereby restraining muscle growth.
Integration of Systemic and Local Cues
In simple terms: Hormones, nutrients, and mechanical load all tell the muscle whether to grow or shrink.
Skeletal muscle growth is influenced by systemic factors such as growth hormone, insulin-like growth factor 1 (IGF-1), androgens, and nutritional status, as well as local mechanical loading. Resistance exercise and time-restricted eating are being studied for their effects on muscle quantity and quality in postmenopausal women, highlighting the interplay between lifestyle and molecular regulators. Additionally, cancer cachexia illustrates how systemic inflammation can override anabolic signals and drive muscle wasting.
Key Genes Involved in GO:0048630 skeletal muscle tissue growth
The following genes and proteins are central to the regulation and execution of skeletal muscle tissue growth (GO:0048630), as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MSTN | Negative regulator of muscle growth; limits hyperplasia and hypertrophy | Knockout leads to massive muscle increase; therapeutic target for muscle wasting |
| PAX7 | Satellite cell marker and regulator of self-renewal | Essential for maintaining muscle stem cell pool |
| MYOD1 | Myogenic determination factor; drives myoblast differentiation | Key transcription factor for muscle lineage commitment |
| MYOG | Myogenin; promotes terminal differentiation and fusion | Marker of differentiation; required for myotube formation |
| MEF2C | Transcription factor cooperating with myogenic factors | Regulates muscle-specific gene expression |
| IGF1 | Anabolic growth factor; activates mTORC1 and protein synthesis | Mediates hypertrophy in response to loading |
| MTOR | Central kinase integrating anabolic signals | Target for muscle growth enhancement |
| FOXO1 | Transcription factor promoting protein degradation | Inhibited by Akt; contributes to atrophy when active |
| FBXO32 | Atrophy-related ubiquitin ligase (MAFbx) | Upregulated in cachexia and sarcopenia |
| TRIM63 | Muscle RING-finger protein 1 (MuRF1); ubiquitin ligase | Mediates myofibrillar protein degradation |
| MYH1 | Myosin heavy chain isoform; contractile protein | Marker of fast-twitch fiber type; increases with hypertrophy |
| ACTA1 | Alpha-actin; major component of thin filaments | Structural protein; synthesis increases during growth |
| DES | Desmin; intermediate filament protein | Maintains sarcomere integrity during growth |
| CDK4 | Cell cycle kinase; promotes satellite cell proliferation | Potential target to enhance muscle regeneration |
| CCND1 | Cyclin D1; regulates G1/S transition in myoblasts | Controls proliferation of activated satellite cells |
| MSTN | Myostatin; negative regulator | See above |
| SMAD3 | Signal transducer downstream of myostatin | Mediates inhibitory effects on myogenesis |
How Is skeletal muscle tissue growth Regulated?
Skeletal muscle tissue growth is regulated by a complex interplay of positive and negative signals. Myostatin (MSTN) acts as a negative regulator; its genetic ablation in mice results in a dramatic increase in muscle mass, demonstrating that myostatin normally restrains growth. Conversely, anabolic pathways such as IGF-1/Akt/mTORC1 promote protein synthesis and hypertrophy. Satellite cell self-renewal and differentiation are controlled by transcription factors including PAX7, MYOD1, and MYOG. Systemic factors such as nutritional status, hormones, and exercise modulate these pathways, as evidenced by studies on resistance training and time-restricted eating in postmenopausal women. In pathological states like cancer cachexia, inflammatory cytokines can activate FOXO transcription factors and ubiquitin ligases (FBXO32, TRIM63), tipping the balance toward muscle wasting.
skeletal muscle tissue growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSTN | Muscle hypertrophy / therapeutic target for wasting | MSTN knockout mouse; overexpression in C2C12 cells |
| FBXO32 | Cancer cachexia; muscle atrophy | Knockout or knockdown in myotubes; cancer cachexia models |
| TRIM63 | Sarcopenia; disuse atrophy | KO mouse models; hindlimb suspension |
| IGF1 | Muscle growth promotion; hypertrophy | Overexpression in skeletal muscle; resistance training models |
| PAX7 | Satellite cell dysfunction in aging | Conditional knockout; lineage tracing |
Cancer Cachexia
Cancer cachexia is a multifactorial syndrome characterized by severe loss of skeletal muscle mass, which cannot be fully reversed by conventional nutritional support. Clinical and biological characterization of skeletal muscle biopsies from surgical cancer patients has revealed alterations in muscle protein turnover and regenerative capacity. Understanding the mechanisms that drive muscle growth may help identify therapeutic targets to counteract cachexia.
Sarcopenia and Aging
Sarcopenia, the age-related loss of muscle mass and function, results from an imbalance between muscle protein synthesis and degradation. Skeletal muscle serves as an experimental model to study tissue aging and rejuvenation, and declines in satellite cell function contribute to impaired muscle growth in the elderly. Interventions such as resistance training and time-restricted eating are being investigated to improve muscle quantity and quality in postmenopausal women.
Muscle Wasting in Chronic Disease
Chronic diseases including chronic kidney disease, heart failure, and COPD are associated with muscle wasting. The ubiquitin-proteasome system, involving FBXO32 and TRIM63, is activated in these conditions, leading to accelerated protein degradation and reduced muscle mass. Strategies to enhance muscle growth, such as myostatin inhibition, are being explored as potential therapies.
From skeletal muscle tissue growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate muscle mass in vivo? | Knockout mouse (e.g., MSTN KO) |
| Does a point mutation in gene X affect protein function? | Point-mutation knock-in mouse or cell line |
| Can a reporter track satellite cell activation? | Knock-in of fluorescent tag (e.g., Pax7-CreERT2) |
| Does overexpression of gene X enhance hypertrophy? | Overexpression in C2C12 myotubes or mouse muscle |
| What is the effect of gene X on myoblast proliferation? | CRISPR knockout in primary satellite cells |
| Does gene X influence muscle growth in a disease context? | Cancer cachexia mouse models with gene editing |
How to Study the skeletal muscle tissue growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Satellite cell isolation and culture | Proliferation and differentiation capacity | In vitro studies of muscle growth |
| RT-qPCR | mRNA expression of myogenic and atrophy genes | Characterization of muscle biopsies |
| RNA-seq | Global transcriptome changes | Identifying pathways in muscle growth |
| Puromycin incorporation | Protein synthesis rate | Assessing anabolic response |
| Histology (H&E, immunofluorescence) | Fiber cross-sectional area, fiber type | Quantifying hypertrophy |
| Grip strength test | Muscle function | Phenotyping knockout mice |
| Western blot | Protein levels of signaling molecules | mTORC1 activity, myostatin signaling |
| CRISPR-Cas9 gene editing | Gene knockout or knock-in | Creating isogenic models |
Satellite Cell Isolation and Culture
Isolation of satellite cells from skeletal muscle tissue allows for in vitro studies of proliferation, differentiation, and self-renewal. Protocols for bovine and human skeletal muscle satellite cells have been established, enabling growth kinetics analysis and differentiation assays. These primary cell models are essential for mechanistic studies of muscle growth.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq can measure the expression of myogenic regulatory factors (e.g., MYOD1, MYOG) and atrophy-related genes (FBXO32, TRIM63) during muscle growth or wasting. Such analyses have been used to characterize muscle biopsies from cancer patients and to assess the effects of interventions like resistance training.
Protein Synthesis and Degradation Assays
Measurement of protein synthesis rates using puromycin incorporation or radioactive tracers, and degradation rates using ubiquitination assays, provides insight into the balance that determines muscle mass. These methods have been applied in hibernation studies to show prioritization of muscle growth.
In Vivo Muscle Function and Size Assessment
Muscle mass can be assessed by weighing muscles, and fiber cross-sectional area can be measured histologically. Grip strength and treadmill tests evaluate function. These approaches are standard in studies of myostatin knockout mice and other models.
How CRISPR Can Be Used to Study GO:0048630 skeletal muscle tissue growth
Knockout
CRISPR-Cas9 knockout of negative regulators such as MSTN in mice or cell lines results in increased muscle mass, validating its role as a growth inhibitor. Knockout of PAX7 in satellite cells impairs self-renewal and muscle growth. These models are invaluable for dissecting gene function in skeletal muscle tissue growth.
Point Mutation
Introducing precise point mutations in genes like MSTN can mimic naturally occurring variants that affect muscle mass in animals and humans. Such models help determine the functional impact of specific amino acid changes on protein activity and muscle growth.
Knock-in
Knock-in of reporter genes (e.g., fluorescent proteins) into endogenous loci such as Pax7 allows real-time tracking of satellite cell activation and differentiation during muscle growth. Knock-in of epitope tags facilitates protein interaction studies.
Overexpression
Overexpression of anabolic genes like IGF1 or constitutively active mTOR in muscle cells or transgenic mice promotes hypertrophy, providing gain-of-function evidence for their role in muscle growth. Conversely, overexpression of myostatin inhibits growth.
How EDITGENE Supports skeletal muscle tissue growth Research
Researchers studying skeletal muscle tissue growth-related genes often need to determine whether a candidate gene is causally involved in muscle hypertrophy, hyperplasia, or wasting. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell and animal models, enabling rigorous functional studies of GO:0048630 and its regulators.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle tissue growth research.
Frequently Asked Questions About skeletal muscle tissue growth
What is GO:0048630?
GO:0048630 is the Gene Ontology term for skeletal muscle tissue growth, defined as the increase in size or mass of a skeletal muscle, which may be due to a change in fiber number or size.
What genes are involved in skeletal muscle tissue growth?
Key genes include MSTN (myostatin), PAX7, MYOD1, MYOG, IGF1, MTOR, and atrophy-related genes FBXO32 and TRIM63.
How does myostatin regulate muscle growth?
Myostatin is a negative regulator; its knockout in mice leads to a dramatic increase in muscle mass, indicating that it normally limits growth.
What are satellite cells and why are they important for muscle growth?
Satellite cells are muscle stem cells that proliferate and differentiate to provide new nuclei for growing muscle fibers; their self-renewal is essential for sustained growth.
What diseases are associated with abnormal skeletal muscle growth?
Cancer cachexia, sarcopenia, and muscle wasting in chronic diseases involve dysregulated muscle growth.
How can I study skeletal muscle tissue growth in the lab?
Methods include satellite cell isolation and culture, gene expression analysis, protein synthesis assays, and in vivo muscle function tests.
What is the role of mTOR in muscle growth?
mTORC1 integrates anabolic signals to promote protein synthesis and hypertrophy; it is a central regulator of muscle growth.
Can CRISPR be used to study muscle growth genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in muscle growth.
What is cancer cachexia and how does it relate to muscle growth?
Cancer cachexia is a wasting syndrome with severe muscle loss; it involves increased protein degradation and reduced growth signaling.
How does aging affect skeletal muscle growth?
Aging leads to sarcopenia, characterized by reduced satellite cell function and anabolic resistance, impairing muscle growth.
Conclusion
Skeletal muscle tissue growth (GO:0048630) is a vital biological process governed by a balance of positive and negative regulators, with myostatin and satellite cells playing central roles. Its dysregulation contributes to major diseases such as cancer cachexia and sarcopenia, making it a key area of biomedical research. Advances in CRISPR gene editing and in vitro models continue to unravel the molecular mechanisms, offering hope for therapeutic interventions that preserve or restore muscle mass.
References
- 1. McPherron AC et al.. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.. Nature 387(6628):83-90 PMID: 9139826
- 2. Miretti S et al.. 2024. Bovine Skeletal Muscle Satellite Cells: Isolation, Growth, and Differentiation.. Methods Mol Biol 2749:165-174 PMID: 38133783
- 3. Etienne J et al.. 2020. Skeletal muscle as an experimental model of choice to study tissue aging and rejuvenation.. Skelet Muscle 10(1):4 PMID: 32033591
- 4. Čamernik K et al.. 2019. Human Skeletal Muscle-Derived Mesenchymal Stem/Stromal Cell Isolation and Growth Kinetics Analysis.. Methods Mol Biol 2045:119-129 PMID: 30499023
- 5. Giordani L et al.. 2018. Satellite Cell Self-Renewal.. Curr Top Dev Biol 126:177-203 PMID: 29304998
- 6. Hindle AG et al.. 2015. Prioritization of skeletal muscle growth for emergence from hibernation.. J Exp Biol 218(Pt 2):276-84 PMID: 25452506
- 7. Alfaro-Magallanes VM et al.. 2025. Effects of time-restricted eating and resistance training on skeletal muscle tissue quantity, quality and function in postmenopausal women with overweight or obesity: A study protocol.. Nutr Metab Cardiovasc Dis 35(5):103844 PMID: 39939249
- 8. Anoveros-Barrera A et al.. 2019. Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.. J Cachexia Sarcopenia Muscle 10(6):1356-1377 PMID: 31307124
